David Ardron

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

P. Mulvenna, Matthew Nankivell, Rachael Barton et al. · The Lancet · 2016 · 727 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Improving the effectiveness of multidisciplinary team meetings for patients with chronic diseases: a prospective observational study

Rosalind Raine, Isla Wallace, Caoimhe Nic a’ Bháird et al. · Health Services and Delivery Research · 2014 · 99 citations · Full text

Nursing, Internal Medicine, Clinical Decision Support +16

Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

N. Bayman, David Ardron, Linda Ashcroft et al. · BMJ Open · 2016 · 31 citations · Full text

Medicine, Oncology, Surgery +17

Whole brain radiotherapy for brain metastases from non-small lung cancer: Quality of life (QoL) and overall survival (OS) results from the UK Medical Research Council QUARTZ randomised clinical trial (ISRCTN 3826061).

P. Mulvenna, Matthew Nankivell, Rachael Barton et al. · Journal of Clinical Oncology · 2015 · 29 citations

Medicine, Oncology, Radiation Oncology +17

Making patient and public involvement in cancer and palliative research a reality: academic support is vital for success

Karen Collins, Jonathan Boote, David Ardron et al. · BMJ Supportive & Palliative Care · 2014 · 25 citations

Medicine, Health Policy, Oncology +15